Therefore, a prospective longitudinal study is needed for investigating changes in body composition and adiponectin and myostatin levels in patients with obesity during a bodyweight loss program. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.